Identification of seven novel nucleotide variants in the hepatocyte nuclear factor-1α (TCF1) promoter region in MODY patients

Human Mutation

Volumn 15, Issue 2, 2000, Pages 173-180

  Godart, François ^a   Bellanné Chantelot, Christine ^b   Clauin, Séverine ^b   Gragnoli, Claudia ^c   Abderrahmani, Amar ^a   Blanché, Hélène ^b   Boutin, Philippe ^a   Chèvre, Jean Claude ^a   Froguel, Philippe ^a   Bailleul, Bernard ^a  

^a INSTITUT DE BIOLOGIE DE LILLE   (France)

^b FONDATION JEAN DAUSSET CEPH   (France)

^c HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

Functional studies; HNF 1 ; MODY3; Promoter variants; TCF1

Indexed keywords

NUCLEAR FACTOR I;

ARTICLE; CONTROLLED STUDY; FAMILY STUDY; GENE MUTATION; GENETIC ANALYSIS; GENETIC LINKAGE; GENETIC SCREENING; HUMAN; HUMAN CELL; MATURITY ONSET DIABETES MELLITUS; NUCLEOTIDE SEQUENCE; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROMOTER REGION; SEQUENCE ANALYSIS;

5' UNTRANSLATED REGIONS; ADULT; AGE OF ONSET; AMINO ACID SEQUENCE; BASE SEQUENCE; CELL LINE; CHILD, PRESCHOOL; CONSENSUS SEQUENCE; DIABETES MELLITUS, TYPE 2; DNA; DNA-BINDING PROTEINS; FEMALE; GENE EXPRESSION REGULATION; HEPATOCYTE NUCLEAR FACTOR 1; HEPATOCYTE NUCLEAR FACTOR 1-ALPHA; HEPATOCYTE NUCLEAR FACTOR 1-BETA; HUMANS; MALE; NUCLEAR PROTEINS; NUCLEOTIDES; PEDIGREE; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROMOTER REGIONS (GENETICS); RESPONSE ELEMENTS; TRANSCRIPTION FACTORS; VARIATION (GENETICS);

EID: 0342905058     PISSN: 10597794     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-1004(200002)15:2<173::AID-HUMU6>3.0.CO;2-W     Document Type: Article

References (36)

1. Amrolia PJ, Cunningham JM, Ney P, Nienhuis AW, Jane SM. 1995. Identification of two novel regulatory elements within the 5′-untranslated region of the human A gamma-globin gene. J Biol Chem 270:12892-12898.
2. Bach I, Yaniv M. 1993. More potent transcriptional activators or a transdominant inhibitor of the HNF1 homeoprotein family are generated by alternative RNA processing. Embo J 12:4229-4242.
3. Baumhueter S, Mendel DB, Conley PB, Kuo CJ, Turk C, Graves MK, Edwards CA, Courtois G, Crabtree GR. 1990. HNF-1 shares three sequence motifs with the POU domain proteins and is identical to LF-B1 and APF. Genes Dev 4:372-379.
4. Blanche H, Hager J, Sun F, Dausset J, Cohen D, Froguel P, Cohen N. 1994. Nonradioactive screening of glucokinase mutations in maturity onset diabetes of the young. Biotechniques 16:866-868, 870, 873-876.
5. Boutin P, Hani EH, Vasseur F, Roche C, Bailleul B, Hager J, Froguel P. 1997. Automated fluorescence-based screening for mutation by SSCP: use of universal M13 dye primers for labeling and detection. Biotechniques 23:358-362.
6. Bullido MJ, Artiga MJ, Recuero M, Sastre I, Garcia MA, Aldudo J, Lendon C, Han SW, Morris JC, Frank A, Vazquez J, Goate A, Valdivieso F. 1998. A polymorphism in the regulatory region of APOE associated with risk for Alzheimer's dementia. Nat Genet 18:69-71.
7. Chevre JC, Hani EH, Boutin P, Vaxillaire M, Blanche H, Vionnet N, Pardini VC, Timsit J, Larger E, Charpentier G, Beckers D, Maes M, Bellanné-Chantelot C, Velho G, Froguel P. 1998. Mutation screening in 18 Caucasian families suggest the existence of other MODY genes. Diabetologia 41:1017-1023.
8. Chouard T, Blumenfeld M, Bach I, Vandekerckhove J, Cereghini S, Yaniv M. 1990. A distal dimerization domain is essential for DNA-binding by the atypical HNF1 homeodomain. Nucleic Acids Res 18:5853-5863.
9. Cox RD, Southam L, Hashim Y, Horton V, Mehta Z, Taghavi J, Lathrop M, Turner R. 1998. UKPDS 31: Hepatocyte nuclear factor-1alpha (the MODY3 gene) mutations in late onset type II diabetic patients in the United Kingdom. Diabetologia:120-121.
10. Dix DJ, Lin PN, Kimata Y, Theil EC. 1992. The iron regulatory region of ferritin mRNA is also a positive control element for iron-independent translation. Biochemistry 31:2818-2822.
11. Frain M, Swart G, Monaci P, Nicosia A, Stampfli S, Frank R, Cortese R. 1989. The liver-specific transcription factor LF-B1 contains a highly diverged homeobox DNA binding domain. Cell 59:145-157.
12. Frayling TM, Bulamn MP, Ellard S, Appleton M, Dronsfield MJ, Mackie AD, Baird JD, Kaisaki PJ, Yamagata K, Bell GI, Bain SC, Hattersley AT 1997. Mutations in the hepatocyte nuclear factor-1alpha gene are a common cause of maturity-onset diabetes of the young in the U.K. Diabetes 46:720-725.
13. Froguel P, Zouali H, Vionnet N, Velho G, Vaxillaire M, Sun F, Lesage S, Stoffel M, Takeda J, Passa P, Permutt MA, Beckman JS, Bell GI, Cohen D. 1993. Familial hyperglycemia due to mutations in glucokinase. Definition of a subtype of diabetes mellitus. N Engl J Med 328:697-702.
14. Geballe AP, Spaete RR, Mocarski ES. 1986. A cis-acting element within the 5′ leader of a cytomegalovirus beta transcript determines kinetic class. Cell 46:865-872.
15. Glucksmann MA, Lehto M, Tayber O, Scotti S, Berkemeier L, Pulido JC, Wu Y, Nir WJ, Fang L, Markel P, Munnelly KD, Goranson J, Orho M, Young BM, Whitacre JL, McMenimen C, Wantman M, Tuomi T, Warram J, Forsblom CM, Carlsson M, Rosenzweig J, Kennedy G, Duyk GM, Krolewski AS, Groop LC, Thomas JD. 1997. Novel mutations and a mutational hotspot in the MODY3 gene. Diabetes 46:1081-1086.
16. Gragnoli C, Lindner T, Cockburn BN, Kaisaki PJ, Gragnoli F, Marozzi G, Bell GI. 1997. Maturity-onset diabetes of the young due to a mutation in the hepatocyte nuclear factor-4 alpha binding site in the promoter of the hepatocyte nuclear factor-1 alpha gene. Diabetes 46:1648-1651.
17. Hansen T, Eiberg H, Rouard M, Vaxillaire M, Moller AM, Rasmussen SK, Fridberg M, Urhammer SA, Holst JJ, Almind K, Echwald SM, Hansen L, Bell GI, Pedersen O. 1997. Novel MODY3 mutations in the hepatocyte nuclear factor-1alpha gene: evidence for a hyperexcitability of pancreatic beta-cells to intravenous secretagogues in a glucose-tolerant carrier of a P447L mutation. Diabetes 46:726-730.
18. Horikawa Y, Iwasaki N, Hara M, Furuta H, Hinokio Y, Cockburn BN, Lindner T, Yamagata K, Ogata M, Tomonaga O, Kuroki H, Kasahara T, Iwamoto Y, Bell GI. 1997. Mutation in hepatocyte nuclear factor-1 beta gene (TCF2) associated with MODY. Nat Genet 17:384-385.
19. Kaisaki PJ, Menzel S, Lindner T, Oda N, Rjasanowski I, Sahm J, Meincke G, Schulze J, Schmechel H, Petzold C, Ledermann HM, Sachse G, Boriraj VV, Menzel R, Kerner W, Turner RC, Yamagata K, Bell GI. 1997. Mutations in the hepatocyte nuclear factor-1alpha gene in MODY and early-onset NIDDM: evidence for a mutational hotspot in exon 4. Diabetes 46:528-535.
20. Mansour SL, Grodzicker T, Tjian R. 1986. Downstream sequences affect transcription initiation from the adenovirus major late promoter. Mol Cell Biol 6:2684-2694.
21. Mantovani R. 1998. A survey of 178 NF-Y binding CCAAT boxes. Nucleic Acids Res 26:1135-1143.
22. Miquerol L, Lopez S, Cartier N, Tulliez M, Raymondjean M, Kahn A. 1994. Expression of the L-type pyruvate kinase gene and the hepatocyte nuclear factor 4 transcription factor in exocrine and endocrine pancreas. J Biol Chem 269:8944-8951.
23. Pontoglio M, Barra J, Hadchouel M, Doyen A, Kress C, Bach JP, Babinet C, Yaniv M. 1996. Hepatocyte nuclear factor 1 inactivation results in hepatic dysfunction, phenylketonuria, and renal Fanconi syndrome. Cell 84:575-585.
24. Rao CD, Pech M, Robbins KC, Aaronson SA. 1988. The 5′ untranslated sequence of the c-sis/platelet-derived growth factor 2 transcript is a potent translational inhibitor. Mol Cell Biol 8:284-292.
25. Reijnen MJ, Sladek FM, Bertina RM, Reitsma PH. 1992. Disruption of a binding site for hepatocyte nuclear factor 4 results in hemophilia B Leyden. Proc Natl Acad Sci U S A 89:6300-6303.
26. Schreiber E, Matthias P, Muller MM, Schaffner W. 1989. Rapid detection of octamer binding proteins with "mini-extracts," prepared from a small number of cells. Nucleic Acids Res 17:6419.
27. Stoffers DA, Stanojevic V, Habener JF. 1998. Insulin promoter factor-1 gene mutation linked to early-onset type 2 diabetes mellitus directs expression of a dominant negative isoprotein. J Clin Invest 102:232-241.
28. Tian JM, Schibler U. 1991. Tissue-specific expression of the gene encoding hepatocyte nuclear factor 1 may involve hepatocyte nuclear factor 4. Genes Dev 5:2225-2234.
29. Vaxillaire M, Rouard M, Yamagata K, Oda N, Kaisaki PJ, Boriraj VV, Chevre JC, Boccio V, Cox RD, Lathrop GM, Dussoix P, Philippe J, Timsit J, Charpentier G, Velho G, Bell GI, Froguel P. 1997. Identification of nine novel mutations in the hepatocyte nuclear factor 1 alpha gene associated with maturity-onset diabetes of the young (MODY3). Hum Mol Genet 6:583-586.
30. Vaxillaire M, Abderrahmani A, Boutin P, Bailleul B, Froguel P, Yaniv M, Pontoglio M. 1999. Anatomy of a homeoprotein revealed by the analysis of human MODY3 mutations. J Biol Chem 274:35639-35646.
31. Wang H, Maechler P, Hagenfeldt KA, Wollheim CB. 1998. Dominant-negative suppression of HNF-1alpha function results in defective insulin gene transcription and impaired metabolism-secretion coupling in a pancreatic beta-cell line. Embo J 17:6701-6713.
32. Wilhide CC, Jin Y, Guo Q, Li L, Li SX, Rubin E, Bray PF. 1997. The human integrin beta3 gene is 63 kb and contains a 5′-UTR sequence regulating expression. Blood 90:3951-3961.
33. Yamagata K, Furuta H, Oda N, Kaisaki PJ, Menzel S, Cox NJ, Fajans SS, Signorini S, Stoffel M, Bell GI. 1996a Mutations in the hepatocyte nuclear factor-4alpha gene in maturity- onset diabetes of the young (MODY1). Nature 384:458-460.
34. Yamagata K, Oda N, Kaisaki PJ, Menzel S, Furuta H, Vaxillaire M, Southam L, Cox RD, Lathrop GM, Boriraj VV, Chen X, Cox NJ, Oda Y, Yano H, Le Beau MM, Yamada S, Nishigori H, Takeda J, Fajans SS, Hattersley AT, Iwasaki N, Hansen T, Pedersen O, Polonsky KS, Turner RC, Velho G, Chèvre J-C, Froguel P, Bell GI. 1996b Mutations in the hepatocyte nuclear factor-1alpha gene in maturity-onset diabetes of the young (MODY3). Nature 384:455-458.
35. Yamagata K, Yang Q, Yamamoto K, Iwahashi H, Miyagawa J, Okita K, Yoshiuchi I, Miyazaki J, Noguchi T, Nakajima H, Namba M, Hanafusa T, Matsuzawa Y. 1998. Mutation P291fsinsC in the transcription factor hepatocyte nuclear factor-1alpha is dominant negative. Diabetes 47:1231-1235.
36. Yang WS, Nevin DN, Peng R, Brunzell JD, Deeb SS. 1995. A mutation in the promoter of the lipoprotein lipase (LPL) gene in a patient with familial combined hyperlipidemia and low LPL activity. Proc Natl Acad Sci USA 92:4462-4466.